Connection

Thomas Keane to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Thomas Keane has written about Drug Administration Schedule.
Thomas Keane
Connection Strength
0.112
Drug Administration Schedule
  1. PC-SPES withdrawal response. Acta Oncol. 2004; 43(8):772-3.
    View in: PubMed
    Score: 0.050
  2. The Impact of Late Luteinizing Hormone-Releasing Hormone Agonist Dosing on Testosterone Suppression in Patients with Prostate Cancer: An Analysis of United States Clinical Data. J Urol. 2020 Apr; 203(4):743-750.
    View in: PubMed
    Score: 0.037
  3. A phase II study of gemcitabine and irinotecan in patients with locally advanced or metastatic bladder cancer. Am J Clin Oncol. 2014 Apr; 37(2):188-93.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.